SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

ImmunityBio, Inc. is a clinical stage immunotherapy company. It develops next generation therapies that drive immunogenic mechanisms for defeating cancers and infectious diseases. The company's immunotherapy platform activates both the innate and adaptive immune systems to create long term immunological memory. ImmunityBio was founded by Patrick Soon-Shiong in 2014 and is headquartered in San Diego, CA.

ImmunityBio Inc

ImmunityBio is attracting significant attention following the announcement of an exclusive supply agreement for the Tokyo-172 strain of BCG, a strategic move intended to mitigate long-standing U.S. drug shortages and bolster the commercial rollout of Anktiva. The community is actively discussing the potential for a short squeeze and speculating on further regulatory catalysts as the company presents comparative clinical data at the American Urological Association annual meeting.

Gensyn, the Network for Machine Intelligence, is an open infrastructure layer for AI. It provides the foundational infrastructure AI needs to operate at scale, including compute, data, and information exchange, by enabling both humans and machines to participate in open digital markets. Built with native support for AI communication, identification, and verification, Gensyn serves as the economic backbone for continual learning over new decentralised AI models and applications, without centralised control.  Gensyn is backed by a16z crypto, CoinFund, Galaxy Digital, Eden Block, Maven 11, and more. For more information, visit http://gensyn.ai

Gensyn

Gensyn is capturing significant community attention following its recent listings on major cryptocurrency exchanges like Coinbase and Binance. Investors are actively discussing the token's potential role in the expanding artificial intelligence sector, driven by enthusiasm for its decentralized machine intelligence protocol and optimistic sentiment regarding future adoption.

ServiceNow, Inc. engages in the provision of an end-to-end workflow automation platform for digital businesses. Its Now Platform is a cloud-based solution embedded with artificial intelligence (AI) and machine learning (ML). The company was founded by Frederic B. Luddy in June 2004 and is headquartered in Santa Clara, CA.

ServiceNow Inc

ServiceNow is seeing significant upward momentum as investors speculate on a rotation into software stocks, further fueled by recent disclosures that the former President has established a substantial position in the company. The community is actively discussing the stock's role as a mission-critical platform for enterprise AI and workflows, debating whether this strength signals a sustainable trend or a temporary relief rally.

Bitmine Immersion Technologies, Inc. is a technology company focused on acquiring, holding, and actively managing ETH as its primary treasury reserve asset. It prioritizes digital ecosystem services, such as consultancy and advisory works. The company was founded on August 16, 1995 and is headquartered in Las Vegas, NV.

BitMine Immersion Technologies Inc

Bitmine Immersion Technologies Inc

Bitmine Immersion Technologies (BMNR) is facing intense community debate following news that the company is slowing down its aggressive Ethereum accumulation, leading to frustration among retail investors concerned about recent dilution. While some investors see the stock as an undervalued long-term proxy for Ethereum, others are increasingly vocal about their dissatisfaction with management's transparency and the stock's persistent underperformance compared to broader market trends.

NVIDIA Corp. engages in the design and manufacture of computer graphics processors, chipsets, and related multimedia software. It operates through the following segments: Graphics Processing Unit (GPU) and Compute & Networking. The Graphics segment includes GeForce GPUs for gaming and PCs, the GeForce NOW game streaming service and related infrastructure, Quadro and NVIDIA RTX GPUs for enterprise workstation graphics, virtual GPU, or vGPU, software for cloud-based visual and virtual computing, automotive platforms for infotainment systems, and Omniverse Enterprise software for building and operating metaverse and 3D internet applications. The Compute & Networking segment consists of Data Center accelerated computing platforms and end-to-end networking platforms including Quantum for InfiniBand and Spectrum for Ethernet, NVIDIA DRIVE automated-driving platform and automotive development agreements, Jetson robotics and other embedded platforms, NVIDIA AI Enterprise and other software, and DGX Cloud software and services. The company was founded by Jen Hsun Huang, Chris A. Malachowsky, and Curtis R. Priem in April 1993 and is headquartered in Santa Clara, CA.

NVIDIA Corp

NVIDIA is currently a primary focal point for investors as they weigh the potential for a blowout earnings report against significant geopolitical volatility surrounding China trade relations. Community sentiment is deeply divided, with bulls looking to leverage heavy institutional call volume ahead of the earnings event, while bears are increasingly wary of valuation fatigue and broader macroeconomic headwinds.

United States Antimony Corp. engages in the extraction, processing and sale of antimony, zeolite, silver, and gold products. It operates through the following segments: United States Antimony Operations, Mexican Antimony Operations, Precious Metals Recovery, and United States Zeolite Operations. The company was founded by John C. Lawrence in June 1968 and is headquartered in Dallas, TX.

United States Antimony Corp.

United States Antimony Corp. is trending as investors react to a disappointing quarterly performance while maintaining high expectations for its upcoming smelter expansion and government-backed critical mineral initiatives. The community remains deeply divided, with some traders expressing frustration over executive execution and short-term volatility, while others view the current price action as an institutional accumulation opportunity ahead of anticipated production ramp-ups later this year.

Lynas Rare Earths Ltd. engages in the production of rare earth minerals. It focuses on the exploration, development, mining, and processing of rare earth deposits. The company was founded by Nicholas Anthony Curtis on May 23, 1983 and is headquartered in Perth, Australia.

Lynas Rare Earths Limited

Lynas Rare Earths is seeing significant investor attention driven by rising geopolitical demand for non-Chinese critical mineral supply chains, underscored by its strategic expansion into U.S.-based processing and defense-focused production. The community is actively monitoring institutional sentiment, the company's role as the largest producer outside of China, and its progress in fulfilling critical off-take agreements to secure supply for high-growth sectors like electric vehicles and defense.

Rumble, Inc. engages in operating an online neutral video platform. It operates through the following geographical segments: United States, Canada, and Other. The company was founded in October 2013 by Chris Pavlovski and is headquartered in Longboat Key, FL.

Rumble Inc - Ordinary Shares - Class A

Rumble Inc

Rumble is trending as investors focus on the company's transformation from a video platform into a cloud and AI infrastructure provider, fueled by its pending acquisition of Northern Data. Community sentiment is heavily centered on the anticipated revenue growth from these new data center assets and potential short squeeze dynamics driven by high short interest.

NIO, Inc. operates as a holding company, which engages in the design, development, manufacture, and sale of smart electric vehicles. It offers its products under the brands NIO, ONVO, and FIREFLY. The company was founded by Bin Li and Li Hong Qin on November 28, 2014 and is headquartered in Shanghai, China.

NIO Inc - ADR

NIO Inc

NIO is trending as the market anticipates high-level trade discussions between U.S. and Chinese leadership, fueling speculation about potential manufacturing partnerships and increased international market access. Community discussion is heavily divided between bulls highlighting the company's strong charging infrastructure and upcoming earnings, and bears expressing deep skepticism regarding past dilution and the stock's long-term performance.

e.l.f. Beauty, Inc. is a holding company, which engages in the provision of inclusive, accessible, clean, vegan and cruelty free cosmetics and skin care products. The company focuses on the e-commerce, national retailers and international business channels. Its brands include elf, elf skin, naturium, well people, and keys soulcare. The company was founded in 2004 and is headquartered in Oakland, CA.

e.l.f. Beauty Inc

e.l.f. Beauty is experiencing significant volatility as investors debate the impact of potential tariff relief and broader retail sector rotation versus persistent concerns over consumer discretionary spending. The community remains deeply divided, with many traders accumulating shares on dips in anticipation of an earnings-driven recovery while others remain cautious due to recent downward momentum and insider activity.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

BDTX Shares Gain 11% in a Week: Here's What You Should Know

Black Diamond stock rises after its Q1 results reflect lower costs, a cash runway into 2028 and continued progress for lead candidate silevertinib.

Black Diamond Therapeutics (BDTX) to Release Quarterly Earnings on Monday

Black Diamond Therapeutics (NASDAQ:BDTX) will be releasing its Q1 2026 earnings before the market opens on Monday, May 11. (View Earnings Report at https://www.marketbeat.com/earnings/reports/2026-5-11-black-diamond-therapeutics-inc-stock...

HC Wainwright Issues Positive Forecast for BDTX Earnings

Black Diamond Therapeutics, Inc. (NASDAQ:BDTX - Free Report) - HC Wainwright upped their Q1 2026 earnings estimates for shares of Black Diamond Therapeutics in a research note issued on Wednesday...

Implied Volatility Surging for Black Diamond Therapeutics Stock Options

Investors need to pay close attention to BDTX stock based on the movements in the options market lately.

Jefferies Financial Group Upgrades Black Diamond Therapeutics (NASDAQ:BDTX) to Strong-Buy

Jefferies Financial Group upgraded shares of Black Diamond Therapeutics to a "strong-buy" rating in a report on Thursday...

BDTX and the CNS-Active EGFR Trend: Why C797S Is the Prize

Black Diamond Therapeutics bets on brain-penetrant EGFR drug silevertinib, targeting C797S resistance and CNS metastases as key edge in crowded lung cancer market.

BDTX Stock: Neutral Zacks Rank, $4 Target, and What Must Go Right

Black Diamond Therapeutics hinges on silevertinib, with 2026 data on progression-free survival and durability set to determine whether its single-asset story can justify upside.

Black Diamond's Lead Drug Silevertinib: Key Data, Catalysts, and Risks

BDTX rides on silevertinib, with 2026 durability data set to test early NSCLC efficacy and CNS signals, making upcoming readouts a decisive swing factor.

Why Is Black Diamond (BDTX) Up 19.3% Since Last Earnings Report?

Black Diamond (BDTX) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

Black Diamond Therapeutics, Inc. (NASDAQ:BDTX) Receives Consensus Rating of "Moderate Buy" from Analysts

Black Diamond Therapeutics, Inc. (NASDAQ:BDTX - Get Free Report) has received a consensus rating of "Moderate Buy" from the eight analysts that are currently covering the firm, MarketBeat reports...

Black Diamond Therapeutics, Inc. is a clinical-stage oncology company developing MasterKey therapies that target families of oncogenic mutations in patients with cancer. The company’s MasterKey therapies are designed to address a broad spectrum of genetically defined tumors, overcome resistance, minimize wild-type-mediated toxicities, and be brain-penetrant to treat central nervous system diseases. It is currently focused on advancing a Phase 2 NSCLC trial of BDTX-1535, a brain-penetrant, fourth-generation epidermal growth factor receptor (EGFR) MasterKey inhibitor targeting EGFR-mutant NSCLC and glioblastoma. The company was founded by David M. Epstein and Elizabeth Buck in 2014 and is headquartered in Cambridge, MA.

Current Price	$2.75
Prev Close	$2.86
Open	$2.82
Dividend Yield	0.00%
50-Day Moving Average	$2.55
Beta	1.96
Avg. Volume	841,419.91
PE Ratio	-3.63

52-Week High	$4.94
52-Week Low	$1.90
Market Capitalization	$157.58M
EPS (Annual)	$0.3886
Price to Book	1.51
Revenue Per Employee	$3.33M

BDTX
Black Diamond Therapeutics Inc

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest BDTX News

BDTXBlack Diamond Therapeutics Inc